AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Neuromodulation Market 2020-2024 | Evolving Opportunities with Abbott Laboratories and Boston Scientific Corp. | Technavio

January 6, 2020 GMT
Global Neuromodulation Market 2020-2024 | Evolving Opportunities with Abbott Laboratories and Boston Scientific Corp. | Technavio
Global Neuromodulation Market 2020-2024 | Evolving Opportunities with Abbott Laboratories and Boston Scientific Corp. | Technavio

LONDON--(BUSINESS WIRE)--Jan 6, 2020--

Technavio has been monitoring the global neuromodulation market since 2019 and the market is poised to grow by USD 5.2 billion during 2020-2024, progressing at a CAGR of more than 11% during the forecast period. Request free sample pages

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200106005069/en/

Technavio has announced its latest market research report titled global neuromodulation market 2020-2024 (Graphic: Business Wire)

Read the 167-page report with TOC on “Neuromodulation Market Analysis Report by Geography (Asia, Europe, North America, and ROW), Product (Implantable neuromodulation devices and External neuromodulation devices), and the Segment Forecasts, 2020-2024.”

https://www.technavio.com/index.php?route=product/product&product_id=211135

The market is driven by technological advances. In addition, expanding indications are anticipated to boost the growth of the neuromodulation market.

The market is witnessing significant technological advancements related to battery longevity and miniaturization of neuromodulation devices. Some of the technological advancements include improved device software and programming, the introduction of rechargeable batteries, and implantation techniques. These technological advancements have significantly enhanced the reliability and effectiveness of neuromodulation devices. Key vendors are introducing MRI-conditional implantable neuromodulation devices that do not get affected when patients undergo MR imaging examinations. Such technological advances are expected to drive the demand for neuromodulation devices during the forecast period.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Major Five Neuromodulation Market Companies:

Abbott Laboratories

Abbott Laboratories operates the business across segments such as Established Pharmaceuticals, Diagnostics, Nutritionals, and Cardiovascular and Neuromodulation. The company offers a wide range of neuromodulators. Some of the key offerings of the company include NT2000IX Radiofrequency Generator, Proclaim DRG Neurostimulator System, Proclaim Elite Recharge-Free SCS System, Prodigy MRI SCS System, St. Jude Medical Infinity DBS System, St. Jude Medical Invisible Trial System, St. Jude Medical Invisible Trial System, and Simplicity Probe.

Boston Scientific Corp.

Boston Scientific Corp. operates the business across segments such as Cardiovascular, Rhythm and Neuro, and MedSurg. The company offers a wide range of neuromodulation devices. Vercise Primary Cell (PC), Vercise Gevia DBS Systems, and Spectra WaveWriter SCS System are some of its key offerings.

LivaNova Plc

LivaNova Plc operates the business across segments such as Cardiopulmonary Products, Heart Valves and Repair Products, Advanced Circulatory Support Products, and Neuromodulation. VNS Therapy System and aura6000 are the key offerings of the company.

Medtronic Plc

Medtronic Plc operates the business across segments such as Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The company offers a wide range of neuromodulation devices. Some of the key offerings of the company include Activa PC, Activa SC, Activa RC, InterStim Quad Lead Tined (3889), RestoreSensor SureScan MRI (97714), PrimeAdvanced (37702), PrimeAdvanced SureScan MRI (97702), RestoreSensor (37714), RestoreAdvanced (37713), Intellis with AdaptiveStim (97715), RestoreAdvanced SureScan MRI (97713), Itrel 4 (37703), and RestoreUltra SureScan MRI (97712).

NeuroMetrix Inc.

NeuroMetrix Inc. operates the business in the Medical equipment and consumables segment. Quell 2.0 and Quell are the key product offerings of the company.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio’s SUBSCRIPTION platform

Neuromodulation Product Outlook (Revenue, USD Billion, 2020 - 2024)

Neuromodulation Regional Outlook (Revenue, USD Billion, 2020 - 2024)

Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report

Related Reports on Healthcare include:

Neurodiagnostic and Monitoring Devices Market in the US – Neurodiagnostic and monitoring market in the US by product (ICP monitoring devices, EEG devices, EMG devices, and others).

Global Neuroendoscopy Devices Market – Global neuroendoscopy devices market by geography (Asia, Europe, North America, and ROW) and product (rigid and semi-rigid endoscopes and flexible endoscopes).

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com

View source version on businesswire.com:https://www.businesswire.com/news/home/20200106005069/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

www.technavio.com

Follow Us: LinkedIn | Twitter

KEYWORD:

INDUSTRY KEYWORD: MEDICAL DEVICES HEALTH

SOURCE: Technavio

Copyright Business Wire 2020.

PUB: 01/06/2020 07:30 AM/DISC: 01/06/2020 07:30 AM

http://www.businesswire.com/news/home/20200106005069/en